Copyright
©The Author(s) 2022.
World J Gastroenterol. Jan 14, 2022; 28(2): 242-262
Published online Jan 14, 2022. doi: 10.3748/wjg.v28.i2.242
Published online Jan 14, 2022. doi: 10.3748/wjg.v28.i2.242
Table 10 Tumor necrosis factor-alpha-1030 polymorphism and gastric cancer association risk in gastric cancerous patients and subjects with benign gastric disorders, n (%)
Gastric pathologies | OR (95%CI) | ||
Benign disorders1 , n = 108 | Cancer, n = 14 | ||
Allele frequency | |||
TNF-A-1030-T | 176 (90.28) | 21 (75.00) | 1.150 (0.4627 - 2.8600) |
TNF-A-1030-C | 51 (9.72) | 7 (25.00) | |
P value | 0.8116 | ||
Genotype frequency | |||
T/T | 68 (62.96) | 7 (50.00) | 1.700 (0.5556 - 5.2020) |
C carrier | 40 (37.04) | 7 (50.00) | |
P value | 0.3900 |
- Citation: Idris AB, Idris AB, Gumaa MA, Idris MB, Elgoraish A, Mansour M, Allam D, Arbab BM, Beirag N, Ibrahim EAM, Hassan MA. Identification of functional tumor necrosis factor-alpha promoter variants associated with Helicobacter pylori infection in the Sudanese population: Computational approach. World J Gastroenterol 2022; 28(2): 242-262
- URL: https://www.wjgnet.com/1007-9327/full/v28/i2/242.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i2.242